CTSS and stroke disorder: To determine functional implications of Ctss expression and secretion in the stroke-induced blood brain barrier dysfunction, we used morpholinurea-leucine-homophenylalanine-vinyl phenyl sulfone (LHVS), which is an irreversible Ctss inhibitor[14].